Middleton, R., Simpson-Yap, S., Pirmani, A., Brouwer, E. D., Peeters, L. M., Geys, L., . . . Kalincik, T. (2022). Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-β. Multiple Sclerosis and Related Disorders, 66, p. 104072. doi:10.1016/j.msard.2022.104072
Chicago Style CitationMiddleton, Rod, et al. "Severity of COVID19 Infection Among Patients With Multiple Sclerosis Treated With Interferon-β." Multiple Sclerosis and Related Disorders 66 (2022): 104072.
MLA CitationMiddleton, Rod, et al. "Severity of COVID19 Infection Among Patients With Multiple Sclerosis Treated With Interferon-β." Multiple Sclerosis and Related Disorders 66 (2022): 104072.
Warning: These citations may not always be 100% accurate.